Hybrid Therapy for Spinal Metastases
- PMID: 32147010
- DOI: 10.1016/j.nec.2019.11.001
Hybrid Therapy for Spinal Metastases
Abstract
The combination of separation surgery and stereotactic body radiotherapy optimizes the treatment of metastatic spine tumors. The integration of SBRT into treatment paradigms produces superb local control rates and consequently has diminished the role of surgery from principle treatment to one of adjuvant therapy. Under this paradigm, hybrid therapy for the treatment of metastatic spine tumors employs separation surgery to decompress the spinal cord and stabilize the spine while creating a safe target for ablative SBRT. Hybrid therapy is well tolerated, allows an early return to systemic therapy, and provides durable, local tumor control compared with more aggressive traditional approaches.
Keywords: Hybrid therapy; Metastases; Radiation; Radiosurgery; Separation surgery; Spinal cord; Spine; Tumor.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Dr M.H. Bilsky receives consulting fees from DePuy/Synthes, Globus, and Brainla; Dr O. Barzilai: fellowship support to his institution from Globus for work performed outside of the current study; Dr D.M. Sciubba: Consultant for Baxter, DePuy-Synthes, Globus Medical, K2M, Medtronic, NuVasive. Unrelated grant funding from Baxter, North American Spine Society, Stryker. Drs R. Rothrock, Z. Pennington, J. Ehresman and N.J. Szerlip have nothing to dosclose.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
